| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |